Genome-wide, high-content siRNA screening identifies the Alzheimer’s genetic risk factor FERMT2 as a major modulator of APP metabolismJean‐Charles Lambert, Fanny Eysert, Virginie Pottiez et al.|Acta Neuropathologica|2016Cited by 78
High‐Content Screening of Synaptic Density Modulators in Primary Neuronal CulturesAudrey Coulon, Julien Chapuis, Dolores Siedlecki‐Wullich et al.|Current Protocols|2023Cited by 3